Literature DB >> 28075321

Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease.

David M Small1, Kassia S Beetham2, Erin J Howden2, David R Briskey2, David W Johnson1,3, Nicole M Isbel1,3, Glenda C Gobe1, Jeff S Coombes2.   

Abstract

OBJECTIVES: Determine the effects of a 12-month exercise and lifestyle intervention program on changes in plasma biomarkers of oxidative stress in pre-dialysis chronic kidney disease (CKD) patients.
METHODS: A total of 136 stage 3-4 CKD patients were randomized to receive standard nephrological care with (N = 72) or without (N = 64) a lifestyle and exercise intervention for 12 months. Plasma total F2-isoprostanes (IsoP), glutathione peroxidase (GPX) activity, total antioxidant capacity (TAC), anthropometric and biochemical data were collected at baseline and at 12 months.
RESULTS: There were no significant differences between groups at baseline. There were no significant differences in changes for standard care and lifestyle intervention, respectively, in IsoP (p = 0.88), GPX (p = 0.87), or TAC (p = 0.56). Patients identified as having high IsoP at baseline (>250 pg/mL) had a greater decrease in IsoP with lifestyle intervention compared to standard care; however, the difference was not statistically significant (p = 0.06). There was no difference in the change in kidney function (eGFR) between standard care and lifestyle intervention (p = 0.33). DISCUSSION: Exercise and lifestyle modification in stage 3-4 CKD did not produce changes in systemic biomarkers of oxidative stress over a 12-month period, but patients with high IsoP may benefit most from the addition of intervention to standard care.

Entities:  

Keywords:  Chronic kidney disease; exercise and lifestyle modification; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28075321      PMCID: PMC6837678          DOI: 10.1080/13510002.2016.1276314

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  43 in total

1.  Estimation of oxidative stress markers in chronic kidney disease.

Authors:  Agnieszka Kuchta; Anastasis Pacanis; Barbara Kortas-Stempak; Agnieszka Cwiklińska; Marcin Ziętkiewicz; Marcin Renke; Boleslaw Rutkowski
Journal:  Kidney Blood Press Res       Date:  2010-11-11       Impact factor: 2.687

2.  Limitations of serum values to estimate glomerular filtration rate during exercise.

Authors:  Jacques R Poortmans; Béatrice Gulbis; Edward De Bruyn; Stéphane Baudry; Alain Carpentier
Journal:  Br J Sports Med       Date:  2012-07-07       Impact factor: 13.800

Review 3.  Oxidative stress, anti-oxidant therapies and chronic kidney disease.

Authors:  David M Small; Jeff S Coombes; Nigel Bennett; David W Johnson; Glenda C Gobe
Journal:  Nephrology (Carlton)       Date:  2012-05       Impact factor: 2.506

Review 4.  Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer.

Authors:  Morihiro Matsuda; Iichiro Shimomura
Journal:  Obes Res Clin Pract       Date:  2013 Sep-Oct       Impact factor: 2.288

5.  Importance of understanding pre-analytical variability in biomarker development.

Authors:  Natalie A Strobel; Robert G Fassett; Susan A Marsh; Jeff S Coombes
Journal:  Int J Cardiol       Date:  2011-06-12       Impact factor: 4.164

Review 6.  Clinical and research markers of oxidative stress in chronic kidney disease.

Authors:  Patrick Steven Tucker; Vincent James Dalbo; Thin Han; Michael Ian Kingsley
Journal:  Biomarkers       Date:  2013-01-23       Impact factor: 2.658

7.  Cystatin C for glomerular filtration rate estimation: coming of age.

Authors:  Andrew S Levey; Li Fan; John H Eckfeldt; Lesley A Inker
Journal:  Clin Chem       Date:  2014-05-28       Impact factor: 8.327

8.  Oxidative stress is progressively enhanced with advancing stages of CKD.

Authors:  Evangelia Dounousi; Eleni Papavasiliou; Areti Makedou; Kyriakos Ioannou; Konstantinos P Katopodis; Alexandros Tselepis; Kostas C Siamopoulos; Dimitrios Tsakiris
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

9.  Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle.

Authors:  Axel Linke; Volker Adams; Paul Christian Schulze; Sandra Erbs; Stephan Gielen; Eduard Fiehn; Sven Möbius-Winkler; Andreas Schubert; Gerhard Schuler; Rainer Hambrecht
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

10.  F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans.

Authors:  J Helmersson; S Basu
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2001-08       Impact factor: 4.006

View more
  4 in total

1.  Protective effect of aerobic exercise on the vocal folds against cigarette smoke exposure.

Authors:  Ceren Ersoz Unlu; Özlem Akkoca; Ilkan Tatar; Mustafa Fevzi Sargon; Dilara Zeybek; Serpil Oguztuzun
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-12       Impact factor: 2.503

2.  Aerobic Exercise Attenuates Kidney Injury, Improves Physical Performance, and Increases Antioxidant Defenses in Lungs of Adenine-Induced Chronic Kidney Disease Mice.

Authors:  Débora Melissa Petry Moecke; Gisele Henrique Cardoso Martins; Thaine Cristina Garlet; Kelly Cattelan Bonorino; Marilia Gabriela Luciani; Monique Bion; Barbara Dos Santos; Monique da Silva Gevaerd; Jamil Assreuy Filho; Adair Roberto Soares Dos Santos; Daniella Serafin Couto Vieira; Alcir Luiz Dafre; Deborah de Camargo Hizume Kunzler
Journal:  Inflammation       Date:  2022-06-21       Impact factor: 4.657

3.  Interventions for weight loss in people with chronic kidney disease who are overweight or obese.

Authors:  Marguerite M Conley; Catherine M McFarlane; David W Johnson; Jaimon T Kelly; Katrina L Campbell; Helen L MacLaughlin
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

4.  Effects of exercise on kidney and physical function in patients with non-dialysis chronic kidney disease: a systematic review and meta-analysis.

Authors:  Keisuke Nakamura; Tomohiro Sasaki; Shuhei Yamamoto; Hiroto Hayashi; Shinji Ako; Yuu Tanaka
Journal:  Sci Rep       Date:  2020-10-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.